Becker's Healthcare September 10, 2025
HHS and the FDA are taking measures to crack down on misleading pharmaceutical advertisements, including digital and broadcast drug ads.
The FDA is sending roughly 100 cease-and-desist letters and thousands of warning letters to drug companies, citing “widespread violations” and deceptive marketing practices, according to a Sept. 9 news release from the FDA.
The agencies are also beginning a rule-making process to eliminate a provision from 1997 that has allowed companies...
Today's Sponsors
Today's Sponsor